Back to Journals » ImmunoTargets and Therapy
ImmunoTargets and Therapy
ISSN: 2253-1556

Editor-in-Chief: Professor Michael R Shurin
ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (138)
- Volume 11, 2022 (3)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Latest articles:
- 5 records -
Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2
Wang LG, Wang L
ImmunoTargets and Therapy 2022, 11:23-35
Published Date: 18 May 2022
Immunotargets and Therapy for Prurigo Nodularis
Labib A, Ju T, Vander Does A, Yosipovitch G
ImmunoTargets and Therapy 2022, 11:11-21
Published Date: 26 April 2022
Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma
Lin AY, Schnitter JM, Gordon LI
ImmunoTargets and Therapy 2022, 11:1-10
Published Date: 23 February 2022
Pathophysiology of Non-IgE-Mediated Food Allergy
Zhang S, Sicherer S, Berin MC, Agyemang A
ImmunoTargets and Therapy 2021, 10:431-446
Published Date: 29 December 2021
Understanding and Managing Severe Asthma in the Context of COVID-19
Kong-Cardoso B, Ribeiro A, Aguiar R, Pité H, Morais-Almeida M
ImmunoTargets and Therapy 2021, 10:419-430
Published Date: 11 December 2021